News

REGENXBIO Announces Participation in Investor Conferences

REGENXBIO Announces Participation in Investor Conferences

REGENXBIO's Upcoming Participation in Investor Conferences

REGENXBIO Inc. (NASDAQ: RGNX) has exciting news as it prepares to participate in several notable upcoming investor conferences. These events showcase the company's dedication to transparency and engagement with its stakeholders while highlighting its advancements in gene therapy.

Key Conferences On The Horizon

The company is scheduled to present at the prestigious BofA Securities Health Care Conference, a significant event for stakeholders in the healthcare sector. This influential conference is an essential platform for REGENXBIO to present its latest innovations and engage with investors. The specifics of the event include a presentation set for a Tuesday afternoon, where key insights will be shared regarding the company’s future directions.

RBC Global Healthcare Conference

Following the BofA conference, REGENXBIO will also participate in the RBC Global Healthcare Conference. This event is another opportunity for the company's representatives to conduct a fireside chat, allowing for more in-depth discussions about its ongoing projects and the potential impacts of its gene therapies. Investors can look forward to this engagement as it promises valuable insights into the company's growth strategies.

H.C. Wainwright BioConnect

Later in May, REGENXBIO will join the H.C. Wainwright BioConnect, further opening the dialogue with investors about its innovative approaches in biotechnology. This event will also feature a fireside chat where industry experts discuss the future of gene therapy and how REGENXBIO is positioning itself in this evolving landscape.

Stifel Virtual Ophthalmology Forum

Additionally, the Stifel Virtual Ophthalmology Forum will highlight REGENXBIO's commitment to advancing treatments within ophthalmology. Here, the company will offer insights into its pipeline focusing on ocular therapies, including innovative treatments for retinal diseases. This is a crucial sector for REGENXBIO as it aligns with their goal to address significant unmet medical needs.

About REGENXBIO Inc.

Founded in 2009, REGENXBIO Inc. is at the forefront of biotechnology, particularly in the realm of gene therapy. Its mission is centered on improving therapeutic outcomes with its cutting-edge AAV (adeno-associated virus) technology. The company is committed to developing a robust pipeline of one-time treatments targeting rare diseases and conditions affecting the retina.

Among its numerous initiatives, REGENXBIO is advancing treatments like RGX-202 for Duchenne muscular dystrophy and clemidsogene lanparvovec (RGX-121) aimed at MPS II, with partners including Nippon Shinyaku. Additionally, the company is making strides with surabgene lomparvovec (ABBV-RGX-314) for wet AMD and diabetic retinopathy in collaboration with AbbVie. These advancements underscore REGENXBIO's proactive role in reshaping healthcare delivery through innovative gene therapies.

For further updates and information about their impactful work, investors and interested parties are encouraged to visit the REGENXBIO website, where they can also access live webcasts from the conferences mentioned.

By participating in these conferences, REGENXBIO not only keeps its investors informed but also reinforces its commitment to advancing gene therapy and its diverse pipeline of therapeutic options.

Frequently Asked Questions

What is REGENXBIO's mission?

REGENXBIO is dedicated to improving lives through gene therapy, focusing on innovative solutions for various diseases.

What major conferences will REGENXBIO attend?

REGENXBIO will participate in conferences like the BofA Securities Health Care Conference and the RBC Global Healthcare Conference.

What is the significance of the BofA Healthcare Conference?

This conference is a premier event for health sector networking and showcases advancements in healthcare, making it an important platform for REGENXBIO.

How does REGENXBIO's technology work?

The company utilizes AAV technology to develop powerful gene therapies that target various diseases effectively.

Where can I find more information about REGENXBIO?

Investors can visit REGENXBIO's official website for the latest news, updates, and access to webcast recordings of their presentations.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Decoding CarBravo-Certified vs Traditional Used Cars

Updated Category News Views 20

What’s Behind Door Number One: CarBravo Certification When you walk onto a car lot these days, it's a mixed bag: shiny badges boasting certifications or basic used car signage. For anyone who's spent time around cars, two types stick out—there’s your CarBravo-certified vehicles and your good ol' used cars. Now, Marissa McCoy and Jill Maniaci from Heidebreicht...

Continue Reading
EMCO's New Automated Facility Could Shake Industry

Updated Category News Views 20

A Novel Leap in Production Capacity EMCO Industries just put a solid foot on the accelerator with their brand-new, shiny, fully automated plant over in Claremore, Oklahoma. If you're glancing at heavy-duty trailer springs, you can't ignore the fact that this is a multimillion-dollar investment. Heck, this monstrous 30,000-square-foot facility more than doubles what EMCO...

Continue Reading
Duke Energy's Cost-Protection Plan Shields Ratepayers

Updated Category News Views 18

Shielding Customers From Data Center Costs Let's get right into the thick of it: Duke Energy's latest move is a strategic one, shrouded in industry terms but with a real impact on regular folks' wallets. The company's agreement with heavyweights like Amazon, Google, and Meta aims to protect existing customers in North Carolina from getting hit with the costs of powering...

Continue Reading
Gong, Agentforce, Avoma Crowned 2026 CI Champions

Updated Category News Views 22

Diving Deep into Conversation Intelligence There's a lot to unpack when three software titans hog the spotlight, and that's exactly what's happening in the world of conversation intelligence this year. It's like we've hit the jackpot with Gong, Agentforce Sales, and Avoma carving out their turf as the 2026 Champions, according to the venerable Info-Tech Research Group....

Continue Reading
Vitamin Angels Drives Global Nutrition Advancements

Updated Category News Views 18

Navigating the Waters of Global Nutrition Bet you never thought a vitamin program could spearhead the front lines of healthcare, huh? Vitamin Angels are grinding away under the radar, shifting the landscape for maternal and child nutrition. At the heart of it all is their vision to make UNIMMAP multiple micronutrient supplementation (MMS) a staple in the global playbook....

Continue Reading
Wally Disrupts Dental Industry with $25M Funding

Updated Category News Views 24

A New Breath of Fresh Air for Dental Care Dental visits—a tedious, costly affair we've all dreaded. So, when Wally rolls out an overhaul in this stale landscape, it's worth taking notice. With $25 million in their pockets from Series A funding led by Maveron, Wally's swaggering in with a plan to flip the script on dental care across the nation. Redefining the Dental...

Continue Reading
HelloNation Brings 'Edvertising' to NC REALTORS® Event

Updated Category News Views 25

HelloNation's Bold Step into Real Estate Networking October 8th to the 11th is shaping up to be a pivotal few days in Wilmington, North Carolina. Here’s the scoop: HelloNation, known for its innovative 'edvertising' model, is joining the bustling crowd at the 2026 NC REALTORS® Convention. This isn’t just any get-together—it's the grandest annual jamboree for real...

Continue Reading
C3EL Expands Federal Footprint with Strategic Contracts

Updated Category News Views 8

Pushing Boundaries in Federal Contracts What a ride C3EL's had in Government Fiscal Year 2026! Let me tell you, they’ve bagged a bunch of contracts that’d make any company’s mouth water. Kicking things off, they snagged a prime cybersecurity contract from the U.S. Air Force. Considering our current cybersecurity landscape, that's like striking gold. But they...

Continue Reading
Merit Expands in New York with Bold Acquisition Move

Updated Category News Views 20

Merit Financial's Growth Trajectory Takes a Leap You watch the movers and shakers in this game long enough, and you start to see patterns. Merit Financial Advisors is one of those juggernauts you'd better keep an eye on. These folks just scooped up Moldenhauer & Associates—a firm that's been a staple in Orchard Park, New York—for a cool $1.1 billion worth of client...

Continue Reading
OCI N.V. Secures a Win in Court; EGM Proceeds as Planned

Updated Category News Views 24

OCI Dodges a Bullet in Amsterdam Court Stepping into the courtroom drama, OCI N.V. just took home a win as the Amsterdam Court of Appeal's Enterprise Chamber gave them a clean bill of health, kicking out the inquiry request from VEB and a bunch of other shareholders. The judges weren't convinced there was anything fishy going on, so they tossed the inquiry petition and...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Life's Interconnections: A Philosophical Perspective

Updated Category News Views 247

Voyage into the Depths of Existence A bold inquiry into life’s greatest questions, "Life Revisited" invites readers on a profound journey through the complexities of existence. Laurent Grenier, a Canadian philosopher who has dedicated over 40 years to exploration and reflection, presents this remarkable piece of literature, which synthesizes various viewpoints to offer...

Continue Reading
Mutuum Finance Celebrates Milestones with V1 Protocol and Rapid Growth

Updated Category News Views 175

Exciting Times for Mutuum Finance The DeFi crypto sector is buzzing with activity as new projects emerge, capturing the interest of investors looking for innovative solutions. Among these, Mutuum Finance (MUTM) has recently made headlines by successfully completing the first phase of its roadmap and announcing the upcoming launch of the V1 protocol. Additionally, the...

Continue Reading
Jason Maynard Takes the Helm as CEO of Qualtrics

Updated Category News Views 185

Qualtrics Welcomes Jason Maynard as New CEO Qualtrics, a pioneer in experience management, has recently appointed Jason Maynard as its Chief Executive Officer. Maynard, who will also take a seat on the Qualtrics Board of Directors, officially steps into this influential role today. A Leader with Proven Experience With an impressive background of 30 years in the technology...

Continue Reading
Exciting Growth in the Genome Editing Market for 2032

Updated Category News Views 116

The Expanding Landscape of the Genome Editing Market The global genome editing market is on the brink of significant expansion, projected to grow rapidly at an impressive CAGR of around 13% by 2032. This growth is largely attributed to the rising prevalence of genetic disorders like sickle cell anemia and cystic fibrosis, which are driving the demand for effective gene...

Continue Reading
Celebrating 40 Years of ATS: Innovating Reliability for Manufacturers

Updated Category News Views 200

Advanced Technology Services: A Legacy of Reliability Advanced Technology Services, Inc. (ATS), marks a significant milestone this year as it celebrates 40 years of service excellence in supporting global manufacturers with top-notch reliability solutions. Established with a vision by 32 pioneers from Caterpillar, ATS is known for its commitment to optimize performance...

Continue Reading